stars 1 stars 2 stars 3

For 30 Years, Mimotopes has been a world leader in Custom Peptide Technology and Antibody Production. Mimotopes develops, markets and distributes sophisticated biochemical products and services for the biotech and pharmaceutical industries. Established in Melbourne, Australia in 1989, Mimotopes now has a global customer base with sales offices and distribution channels in the US, UK, Europe, Japan and India. Mimotopes uses proprietary technologies in solid phase synthesis, molecule scavenging applications and biomolecular capture and immobilisation. Coupled with the extensive experience and expertise of its staff, Mimotopes has become one of the global leaders in its field. Mimotopes is the inventor of Peptide Library Technology, Synphase Quantitative Solid Phase Chemistry System, and REPLi off-the -shelf Protease Profiling Technology. Mimotopes provides great before and after sale service. Post graduate friendly!

Mimotopes Questions

The Mimotopes annual revenue was $5.2 million in 2026.

14 people are employed at Mimotopes.

Mimotopes is based in Mulgrave, Victoria.

The NAICS codes for Mimotopes are [54, 54171, 541713, 5417, 541].

The SIC codes for Mimotopes are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users